Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
22 Cards in this Set
- Front
- Back
|
Oxygen Therapy
|
Appropriate management for severe COPD
|
|
|
EXPECTORANTS
|
May be used, but the evidence of effectiveness is anecdotal
|
|
|
MUCOLYTICS
|
May improve sputum clearance and disrupt mucus plugs
|
|
|
Antibiotics
|
Used to treat bacterial infection as evidenced by an increase in volume or change in color or viscosity of the sputum
|
|
|
B2-AGONISTS
|
Control bronchospasm
|
|
|
ANTICHOLINERGICS
|
inhibits contraction of bronchial smooth muscle
|
|
|
THEOPHYLLINE
|
Added to drug regimen after an unsuccessful trial of ipratropium bromide and B2-agonists
|
|
|
CORTICOSTEROIDS
|
Play a less prominent role in COPD than in asthma
|
|
|
B2-AGONISTS
|
Mainstay treatment for COPD
|
|
|
ANTICHOLINERGICS
|
Reduces the volume of sputum without altering its viscosity
|
|
|
THEOPHYLLINE
|
Enhance diaphragmatic contractility
|
|
|
CORTICOSTEROIDS
|
only 10% of COPD patients show subjective benefit and improved lung function
|
|
|
OXYGEN THERAPY
|
For patients with hypoxia
|
|
|
CORTICOSTEROIDS
|
Added to the drug regimen after maximal ipratropium bromide and B2-agonist therapy
|
|
|
THEOPHYLLINE
|
Increase mucociliary clearance
|
|
|
ANTICHOLINERGICS
|
most often administered through metered-dose inhalers, or "puffers”
|
|
|
B2-AGONISTS
`` |
Relieve dyspnea due to airway obstruction
|
|
|
CORTICOSTEROIDS
|
Reduce airway inflammation
|
|
|
THEOPHYLLINE
|
Stimulate the respiratory drive (bronchodilator)
|
|
|
B2-AGONISTS
|
Increase mucociliary clearance by stimulating ciliary activity
|
|
|
CORTICOSTEROIDS
|
Anti-inflammatory
|
|
|
ipratropium bromide
B2-AGONIST |
CORTICOSTEROIDS are added to the drug regimen after maximal______________ and _______ therapy
|
